Treatment response of spirulina, omega-3 fatty acid and Vitamin E & C in OSMF
Phase 4
Completed
- Conditions
- Health Condition 1: - Health Condition 2: K135- Oral submucous fibrosis
- Registration Number
- CTRI/2020/10/028530
- Lead Sponsor
- Maulana Azad Institute of Dental Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 60
Inclusion Criteria
Clinically and histopathologically proven cases of OSMF
Restricted mouth opening
Exclusion Criteria
Patient not willing for participation
Patient with severe systemic disease
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Mouth Opening, Tongue Protrusion, Cheek Flexibility, VAS ScaleTimepoint: Pre treatment, 1 month, 3 months and at the end of 6 months
- Secondary Outcome Measures
Name Time Method Reporting of any malignant transformation in the span of 6 monthsTimepoint: Every 4 weeks till 6 months